Our study addresses this gap by providing the first evidence that Wnt5a/ROR1 signaling upregulates MMP-9, facilitating the degradation of the Matrigel membrane and contributing to the invasiveness of CLL cells—a factor associated with poor clinical outcomes in CLL patients [4, 6]. This evidence concerns the gene WNT5A and B-cell chronic lymphocytic leukemia.